PRLB

Proto Labs, Inc.

$87.73

+0.38% 2026-10-20

IndustrialsS&P 600

1M 3M 6M 1Y 2Y

PRLBSPY

-4.5%

-0.0%

+8.5%

+37.5%

YTD

+73.4%

+63.2%

Live chart

Loading live chart…

Grades vs sector

Momentum

98th pct in sector

A+

12-1 return: +90.6%
Percentile within its GICS sector across the S&P 1500.

Growth

56th pct in sector

B-

Revenue growth (YoY): +10.6%
Percentile within its GICS sector across the S&P 1500.

Value

8th pct in sector

Forward E/P: 2.8% · EBITDA/EV: 3.9%
Percentile within its GICS sector across the S&P 1500.

Profitability

25th pct in sector

D+

Profit margin: +5.4% · Return on equity: +4.5%
Percentile within its GICS sector across the S&P 1500.

Revisions

Not enough data yet

–

EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 5 live models right now.

Quality Growth

not ranked (outside this model's universe or screens)

Momentum Top 15

not ranked (outside this model's universe or screens)

Momentum Blend

not in the current book

New Highs Growth

not ranked (outside this model's universe or screens)

Conviction 20

not in the current book

News

More news

Protolabs Sets Conference Call to Discuss Third Quarter 2026 Financial Results

Business Wire · Oct 09

Arrow Electronics, Methode Electronics, Proto Labs, and SolarEdge Shares Skyrocket, What You Need To Know

StockStory · Oct 02

3 Overrated Stocks We Approach with Caution

StockStory · Oct 02

Strong Revenue and Income Growth Make Proto Labs Stock the ‘Real Deal’

Barchart · Sep 30

Top 3D Printing Stocks to Buy for Solid Long-Term Returns

Zacks · Sep 28

Key stats

Market cap$2.1B

P/E (trailing)69.6

P/E (forward)36.7

52-week range45.10 – 99.96

Revenue growth (YoY, latest qtr)+10.6%

Dividend yield0.00%

Analyst consensusNone (4)

Mean price target$95.50 (+9%)

Valuation and fundamentals

Valuation & fundamentals

Bottom line

Leans expensive

Model read-out from the numbers below, not advice. Score -2 (DCF counts double).

▼DCF (base case)below the price by 53%

▼Forward P/E vs sector36.7x vs median 17.1x

▲Piotroski F-score7/9

▲Altman Z14.3 (safe)

▲Net debt / EBITDA-2.0x

•Analyst target+9% (4 analysts)

Discounted cash flow

Bear

$29

-67%

growth 2% · disc. 12.1% · term. 2.0%

Base

$41

-53%

growth 7% · disc. 11.1% · term. 2.5%

Bull

$55

-37%

growth 10% · disc. 10.1% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 18% a year for 10 years.

Implied

+18%/yr

FCF, last 3 yrs

+14%/yr

FCF, last 5 yrs

+0%/yr

Revenue, last 3 yrs

+3%/yr

Revenue, last 5 yrs

+4%/yr

Same inputs as the DCF above: trailing free cash flow 0.1B, 11.1% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.38 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Industrials

P/E (trailing)

sector median 26.4× · 95th pct

69.6×
pricier

Forward P/E

sector median 17.1× · 98th pct

36.7×
pricier

EV / EBITDA

sector median 14.8× · 92nd pct

28.2×
pricier

Price / sales

sector median 2.1× · 75th pct

3.7×
pricier

Price / book

sector median 3.5× · 43rd pct

3.0×
cheaper

FCF yield

sector median 4.5% · 24th pct

2.7%
pricier

Forward EPS $2.39 vs trailing $1.26 (+89% expected growth). Forward P/E uses analysts' next-12-month estimate.

Backlog (remaining performance obligations)

RPO

$9.6M

as of 2025-12-31

vs a year ago

+10%

YoY

× TTM revenue

0.02×

coverage

22-12

23-12

24-12

25-12

Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).

Quality & financial health

Gross margin

45.4%

Operating margin

6.6%

FCF margin

10.1%

Net margin

5.4%

Return on equity

4.4%

Return on invested capital

4.8%

Net debt / EBITDA

-2.0×

Current ratio

3.6×

Interest cover

–

Cash conversion (OCF/NI)

2.6×

Piotroski F-score 7/9 · last two fiscal years

✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✗ Gross margin improved✓ Asset turnover improved

Altman Z-score 14.3 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target

$96

+9%

Analysts

None

Range

$87–$110

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$533.1M	$21.2M	$59.7M
2024	$500.9M	$16.6M	$68.7M
2023	$503.9M	$17.2M	$45.2M
2022	$488.4M	$-103.5M	$40.4M
2021	$488.1M	$33.4M	$21.0M
2020	$434.4M	$50.9M	$60.0M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +3.0%.

Earnings

Next report: 2026-10-29 · before open · EPS est 0.60

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-07-31	0.54	0.60	+11.5%
2026-05-01	0.39	0.54	+37.8%
2026-02-06	0.34	0.44	+27.9%
2025-10-31	0.39	0.47	+19.9%
2025-07-31	0.34	0.41	+19.9%
2025-05-02	0.29	0.33	+13.0%
2025-02-07	0.32	0.38	+18.8%
2024-11-01	0.32	0.47	+46.0%

Quarterly revenue

Quarter	Revenue	YoY
2026-06-30	$149.3M	+10.6%
2026-03-31	$139.3M	–
2025-12-31	$136.5M	–
2025-09-30	$135.4M	–
2025-06-30	$135.1M	–

Analyst actions

Needham

2026-08-03 · up

Hold → Buy
PT $87

Benchmark

2026-07-06 · main

Buy → Buy
PT $91

Benchmark

2025-11-03 · main

Buy → Buy
PT $55

Cantor Fitzgerald

2025-08-01 · main

Overweight → Overweight
PT $51

Cantor Fitzgerald

2025-02-10 · main

Overweight → Overweight
PT $50

Needham

2025-02-07 · reit

Hold → Hold

Insider trades

Schumacher Daniel

Chief Financial Officer · 2026-09-24

SELL
$476.6K

Schumacher Daniel

Chief Financial Officer · 2026-09-17

SELL
$417.5K

Schumacher Daniel

Chief Financial Officer · 2026-09-16

SELL
$8.5K

Stats refreshed 2026-10-20 18:14:01 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

coteau

Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.

How it works Disclaimer Terms Privacy Data status